Applied Therapeutics, Inc. — Director's Dealing 2025

Jul 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2025-06-09

Reporting Person: Funtleyder Leslie D. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-09	Common Stock	A	150000	—	Acquired	787121	Direct
2025-07-01	Common Stock	A	150000	—	Acquired	937121	Direct

Footnotes

F1: Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following April 1, 2025, subject to the Reporting Person continuing to provide services through each such date.

F2: The total holdings have been adjusted to correct an administrative error in prior Form 4s that resulted in the overstatement of the total holdings.

F3: Consists of compensatory RSUs granted under the Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following July 1, 2025, subject to the Reporting Person continuing to provide services through each such date.